These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8884341

  • 1. A case of hepatocellular carcinoma in HIV-infected patient.
    Tanaka T, Imamura A, Masuda G, Ajisawa A, Negishi M, Tanaka S, Koike M, Hattori N.
    Hepatogastroenterology; 1996; 43(10):1067-72. PubMed ID: 8884341
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma in a patient with primary biliary cirrhosis and seronegativity for markers of hepatitis B virus and hepatitis C virus: report of a case.
    Sunagawa H, Takayama H, Yamashiro T, Sasaki H, Sashida Y, Matsuura K, Kayou M.
    Surg Today; 2003; 33(3):219-23. PubMed ID: 12658391
    [Abstract] [Full Text] [Related]

  • 3. A case of hepatocellular carcinoma in normal liver with no evidence of HBV or HCV infection.
    Tanaka T, Hoshino Y, Hayashi S, Tanaka S, Tsuruta K, Okamoto A, Koike M, Hattori N.
    Hepatogastroenterology; 1996; 43(11):1390-4. PubMed ID: 8908580
    [Abstract] [Full Text] [Related]

  • 4. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients.
    Bruno R, Puoti M, Sacchi P, Filice C, Carosi G, Filice G.
    J Hepatol; 2006; 44(1 Suppl):S146-50. PubMed ID: 16356582
    [Abstract] [Full Text] [Related]

  • 5. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M.
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [Abstract] [Full Text] [Related]

  • 6. A comparison of hepatocellular carcinoma associated with HBV or HCV infection.
    Tanabe G, Nuruki K, Baba Y, Imamura Y, Miyazono N, Ueno K, Arima T, Nakajyou M, Aikou T.
    Hepatogastroenterology; 1999 Feb; 46(28):2442-6. PubMed ID: 10522016
    [Abstract] [Full Text] [Related]

  • 7. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ, North American Liver Cancer in HIV Study Group.
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [Abstract] [Full Text] [Related]

  • 8. Does HIV infection accelerate the development of hepatocellular carcinoma? A case report in a young man.
    Viriyavejakul P, Tangwanicharoen T, Rojanasunan P, Khachansaksumet V.
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):504-6. PubMed ID: 11944707
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [Abstract] [Full Text] [Related]

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 11. Case report. Hepatitis B virus and HIV coinfection.
    Piliero PJ, Faragon JJ.
    AIDS Read; 2002 Oct; 12(10):443-4, 448-51. PubMed ID: 12408101
    [Abstract] [Full Text] [Related]

  • 12. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 13. Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients.
    Mohamed Ael S, al Karawi MA, Mesa GA.
    Hepatogastroenterology; 1997 Sep; 44(17):1404-6. PubMed ID: 9356863
    [Abstract] [Full Text] [Related]

  • 14. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 16. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
    Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G, Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases (GERMVIC Study Group).
    Clin Infect Dis; 2001 Apr 15; 32(8):1207-14. PubMed ID: 11283811
    [Abstract] [Full Text] [Related]

  • 17. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.
    J Gastroenterol Hepatol; 2008 Mar 15; 23(3):459-66. PubMed ID: 17854425
    [Abstract] [Full Text] [Related]

  • 18. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Mar 15; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 19. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.
    J Pathol; 2000 Oct 15; 192(2):207-15. PubMed ID: 11004697
    [Abstract] [Full Text] [Related]

  • 20. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov 15; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.